Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: Different impact on prognosis in clinical practice

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 7, 2012, Pages 735-740

  Kleemann, Thomas ^a   Hochadel, Matthias ^b   Strauss, Margit ^a   Skarlos, Alexandros ^a   Seidl, Karlheinz ^c   Zahn, Ralf ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c KLINIKUM INGOLSTADT   (Germany)

Author keywords

atrial fibrillation; implantable cardioverter defibrillator; inappropriate shock; lead failure; sudden death

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL PRACTICE; CONTROLLED STUDY; DATA ANALYSIS; DEFIBRILLATOR; DISEASE REGISTRY; ELECTRIC SHOCK; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SECONDARY PREVENTION; SUDDEN DEATH; T WAVE;

AGED; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; GERMANY; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863728798     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02279.x     Document Type: Article

References (27)

1. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH,: Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359: 1009-1017.
2. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ,; MADIT II Investigators: Inappropriate implantable cardioverter defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365.
3. van Rees JB, Borleffs CJW, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ,: Inappropriate implantable cardioverter-defibrillator shocks: Incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011; 57: 556-562.
4. Germano JJ, Reynolds MM, Essebag V, Josephson ME,: Frequency and causes of implantable cardioverter-defibrillator therapies: Is device therapy proarrhythmic? Am J Cardiol 2006; 97: 1255-1261.
5. Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM Jr,: Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: Time to go beyond the initial shock. J Am Coll Cardiol 2009; 54: 1993-2000.
6. Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Hallstrom AP, Ledingham RB, Belco KM, Greene HL,; AVID Investigators: Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol 2003; 14: 940-948.
7. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D,: Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946-952.
8. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ,: Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920-2925.
9. Bunch TJ, Day JD, Olshansky B, Stolen KQ, Mullin CM,: Newly detected atrial fibrillation in patients with an implantable cardioverter defibrillator is a strong risk marker of increased mortality. Heart Rhythm 2009; 6: 2-8.
10. Kleemann T, Becker T, Dönges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K,: Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007; 115: 2474-2480.
11. Antonelli D, Rosenfeld T, Freedberg NA, Palma E, Gross JN, Furman S,: Insulation lead malfunction: Is it a matter of insulation coating, venous approach, or both? Pacing Clin Electropyhsiol 1998; 21: 418-421.
12. Mewis C, Kühlkamp V, Dörnberger V, Mermi J, Seipel L,: High incidence of isolator fractures in transvenous implanted cardioverter/ defibrillators. Z Kardiol 1997; 86: 85-94.
13. De Lurgio DB, Sathavorn C, Mera F, Leon A, Walter PF, Langberg JJ,: Incidence and complications of abrasion of implantable cardioverter- defibrillator leads. Am J Cardiol 1997; 79: 1409-1411.
14. Roelke M, O'Nunain SS, Osswald S, Garan H, Harthorne JW, Ruskin JN,: Subclavian crush syndrome complication transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol 1995; 18: 973-979.
15. Becker T, Kleemann T, Strauss M, Doenges K, Schneider S, Senges J, Seidl K,: Long-term prognosis after cardioversion of the first episode of symptomatic atrial fibrillation: A condition believed to be benign revised. Clin Res Cardiol 2008; 97: 74-82.
16. Dorian P, Hohnloser SH, Thorpe KE, Roberts RS, Kuck KH, Gent M, Connolly SJ,: Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: Insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT). Circulation 2010; 122: 2645-2652.
17. Sweeney MO,: The contradiction of appropriate shocks in primary prevention ICDs: Increasing and decreasing the risk of death. Circulation 2010; 122: 2638-2641.
18. Calvi V, Dugo D, Capodanno D, Arancio R, Di Grazia A, Liotta C, Puzzangara E, Ragusa A, Arestia A, Tamburino C,: Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: Do we really need it? Am Heart J 2010; 159: 98-102.
19. Pires LA, Johnson KM,: Intraoperative testing of the implantable cardioverter-defibrillator: How much is enough. J Cardiovasc Electrophysiol 2006; 17: 140-145.
20. Hall B, Jeevanantham V, Levine E, Daubert J, McNitt S, Hall F, Jeevanantham V, Levine E, Daubert J, McNitt S, Hall FM, Jeevanantham V, Levine E, Daubert J, McNitt S, Morady FM, Pelosi F,: Comparison of outcomes in patients undergoing defibrillation threshold testing at the time of implantable cardioverter-defibrillator implantation versus no defibrillation threshold testing. Cardiol J 2007; 14: 463-469.
21. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J,: The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009; 54: 1747-1762.
22. Dünser MW, Hasibeder WR,: Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress. J Intensive Care Med 2009; 24: 293-316.
23. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK,; PREPARE Study Investigators: Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008; 52: 541-550.
24. Gage BF, Watermann AD, Shannon W, Boechler M, Rich MW, Radford MJ,: Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870.
25. Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L, Lee KL, Bardy GH,; Sudden Cardiac Death in Heart Failure Trial Investigators: Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008; 359: 999-1008.
26. Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Sachanandani H, Ellenbogen KA,: Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: A prospective study. Circulation 2010; 122: 1449-1455.
27. Auricchio A, Meijer A, Kurita T, Schloss E, Brinkman K, Claessens-van Ooijen M, Sterns L,: Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: The PainFree SST clinical study design. Europace 2011; 13: 1484-1493.